Chronic use of the immunomodulating tripeptide feG-COOH in experimental feline asthma

Veterinary Immunology and Immunopathology

Volumn 132, Issue 2-4, 2009, Pages 175-180

  Eberhardt, Jason M ^a   DeClue, Amy E ^a   Reinero, Carol R ^a  

^a UNIVERSITY OF MISSOURI   (United States)

Author keywords

Allergy; Animal model; Bronchoalveolar lavage; Cat; Cytokine; Respiratory

Indexed keywords

GAMMA INTERFERON; IMMUNOMODULATING AGENT; INTERLEUKIN 1; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; PLACEBO; SALIVA PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ASTHMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRONCHOSPASM; CAT; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; EOSINOPHIL COUNT; FEMALE; IMMUNOMODULATION; LUNG LAVAGE; MALE; NEUTROPHIL COUNT; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; RESPIRATORY TRACT INFLAMMATION;

ANIMALS; ANTI-ASTHMATIC AGENTS; ANTIGENS, PLANT; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; CAT DISEASES; CATS; CYNODON; CYTOKINES; DISEASE MODELS, ANIMAL; EOSINOPHILS; FEMALE; IMMUNOLOGIC FACTORS; MALE; NEUTROPHILS; OLIGOPEPTIDES;

ANIMALIA; CYNODON DACTYLON; FELIDAE;

EID: 70449522278     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2009.06.004     Document Type: Article

References (31)

1. Baarsch M., Wannemuehler M., Molitor T., and Murtaugh M. Detection of tumor necrosis factor alpha from porcine alveolar macrophages using an L929 fibroblast bioassay. J. Immunol. Methods 140 (1991) 15-22
2. Bijl-Hofland I.D., Folgering H.T., van den Hoogen H., Cloosterman S.G., Van Weel C., Donkers J.M., and van Schayck C.P. Perception of bronchoconstriction in asthma patients measured during histamine challenge test. Eur. Respir. J. 14 (1999) 1049-1054
3. Brightling C., Berry M., and Amrani Y. Targeting TNF-alpha: a novel therapeutic approach for asthma. J. Allergy Clin. Immunol. 121 (2008) 5-10 quiz 11-12
4. Bureau F., Delhalle S., Bonizzi G., Fievez L., Dogne S., Kirschvink N., Vanderplasschen A., Merville M.P., Bours V., and Lekeux P. Mechanisms of persistent NF-kappa B activity in the bronchi of an animal model of asthma. J. Immunol. 165 (2000) 5822-5830
5. Cohn L., Elias J.A., and Chupp G.L. Asthma: mechanisms of disease persistence and progression. Annu. Rev. Immunol. 22 (2004) 789-815
6. DeClue A.E., Cohn L.A., Lechner E.S., Bryan M.E., and Dodam J.R. Effects of subanesthetic doses of ketamine on hemodynamic and immunologic variables in dogs with experimentally induced endotoxemia. Am. J. Vet. Res. 69 (2008) 228-232
7. DeClue A.E., Schooley E., Nafe L.A., and Reinero C.R. feG-COOH blunts eosinophilic airway inflammation in a feline model of allergic asthma. Inflamm. Res. (2009)
8. Dery R.E., Mathison R., Davison J., and Befus A.D. Inhibition of allergic inflammation by C-terminal peptides of the prohormone submandibular rat 1 (SMR-1). Int. Arch. Allergy Immunol. 124 (2001) 201-204
9. Dery R.E., Ulanova M., Puttagunta L., Stenton G.R., James D., Merani S., Mathison R., Davison J., and Befus A.D. Frontline: inhibition of allergen-induced pulmonary inflammation by the tripeptide feG: a mimetic of a neuro-endocrine pathway. Eur. J. Immunol. 34 (2004) 3315-3325
10. Douwes J., Gibson P., Pekkanen J., and Pearce N. Non-eosinophilic asthma: importance and possible mechanisms. Thorax 57 (2002) 643-648
11. Gibson P.G., Simpson J.L., and Saltos N. Heterogeneity of airway inflammation in persistent asthma: evidence of neutrophilic inflammation and increased sputum interleukin-8. Chest 119 (2001) 1329-1336
12. Hirsch S., Frank T.L., Shapiro J.L., Hazell M.L., and Frank P.I. Development of a questionnaire weighted scoring system to target diagnostic examinations for asthma in adults: a modelling study. BMC Fam. Pract. 5 (2004) 30
13. Howarth P.H., Babu K.S., Arshad H.S., Lau L., Buckley M., McConnell W., Beckett P., Al Ali M., Chauhan A., Wilson S.J., Reynolds A., Davies D.E., and Holgate S.T. Tumour necrosis factor (TNFalpha) as a novel therapeutic target in symptomatic corticosteroid dependent asthma. Thorax 60 (2005) 1012-1018
14. Kemp A., Mellow L., and Sabbadini E. Suppression and enhancement of in vitro lymphocyte reactivity by factors in rat submandibular gland extracts. Immunology 56 (1985) 261-267
15. Kirschvink N., Leemans J., Delvaux F., Snaps F., Clerk C., and Gustin P. Functional, inflammatory and morphological characterisation of a cat model of allergic airway inflammation. Vet. J. 174 (2007) 541-553
16. Koh Y.I., Choi I.S., and Lim H. Airway responsiveness as a direct factor contributing to the dyspnoea perception in asthma. Respir. Med. 95 (2001) 464-470
17. Kumar R.K., Webb D.C., Herbert C., and Foster P.S. Interferon-gamma as a possible target in chronic asthma. Inflamm. Allergy Drug Targets 5 (2006) 253-256
18. Lassalle P., Delneste Y., Gosset P., Tonnel A.B., and Capron A. Potential implication of endothelial cells in bronchial asthma. Int. Arch. Allergy Appl. Immunol. 94 (1991) 233-238
19. Lukacs N.W., Strieter R.M., Chensue S.W., Widmer M., and Kunkel S.L. TNF-alpha mediates recruitment of neutrophils and eosinophils during airway inflammation. J. Immunol. 154 (1995) 5411-5417
20. Mathison R., Davison J.S., Befus D., and Abraham W.M. The tripeptide feG inhibits asthmatic reactions in sheep. Immunology 2004 International Proceeding (2004) 515-519
21. Mathison R., Hogan A., Helmer D., Bauce L., Woolner J., Davison J.S., Schultz G., and Befus D. Role for the submandibular gland in modulating pulmonary inflammation following induction of systemic anaphylaxis. Brain Behav. Immunol. 6 (1992) 117-129
22. Mathison R.D., Befus A.D., Davison J.S., and Woodman R.C. Modulation of neutrophil function by the tripeptide feG. BMC Immunol. 4 (2003) 3
23. Norris Reinero C.R., Decile K.C., Berghaus R.D., Williams K.J., Leutenegger C.M., Walby W.F., Schelegle E.S., Hyde D.M., and Gershwin L.J. An experimental model of allergic asthma in cats sensitized to house dust mite or bermuda grass allergen. Int. Arch. Allergy Immunol. 135 (2004) 117-131
24. Ohkawara Y., Lei X.F., Stampfli M.R., Marshall J.S., Xing Z., and Jordana M. Cytokine and eosinophil responses in the lung, peripheral blood, and bone marrow compartments in a murine model of allergen-induced airways inflammation. Am. J. Respir. Cell. Mol. Biol. 16 (1997) 510-520
25. Padrid P., Snook S., Finucane T., Shiue P., Cozzi P., Solway J., and Leff A.R. Persistent airway hyperresponsiveness and histologic alterations after chronic antigen challenge in cats. Am. J. Respir. Crit. Care Med. 151 (1995) 184-193
26. Price D.B., Tinkelman D.G., Nordyke R.J., Isonaka S., and Halbert R.J. Scoring system and clinical application of COPD diagnostic questionnaires. Chest 129 (2006) 1531-1539
27. Ramaswamy K., Mathison R., Carter L., Kirk D., Green F., Davison J.S., and Befus D. Marked antiinflammatory effects of decentralization of the superior cervical ganglia. J. Exp. Med. 172 (1990) 1819-1830
28. Reinero C., DeClue A.E., and Rabinowitz P. Asthma in humans and cats: is there a common sensitivity to aeroallegens in shared environments?. Environ. Res. 109 (2009) 634-640
29. Reinero C., Delgado C., Spinka C.M., DeClue A.E., and Dhand R. Enantiomer-specific effects of albuterol on airway inflammation in healthy and asthmatic cats. Allergy Immunol. 150 (2009) 43-50
30. Reinero C.R., Cohn L.A., Delgado C., Spinka C.M., Schooley E.K., and Declue A.E. Adjuvanted rush immunotherapy using CpG oligodeoxynucleotides in experimental feline allergic asthma. Vet. Immunol. Immunopathol. 121 (2008) 241-250
31. Sternberg E.M. Neuroendocrine regulation of autoimmune/inflammatory disease. J. Endocrinol. 169 (2001) 429-435